About Cotiviti (NYSE:COTV)
Cotiviti Holdings, Inc. is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States. The Company also provides analytics-based solutions unrelated to its healthcare payment accuracy solutions in the United States. Through its Global Retail and Other segment, the Company provides retrospective claims accuracy solutions to retailers primarily in the United States, Canada and the United Kingdom, as well as solutions that manage payment networks for a range of clients. The Company leverages its technology platform, configurable analytics, information assets and expertise in healthcare reimbursement to help its clients develop their claims payment accuracy.
Industry, Sector and Symbol
Industry Medical Software & Technology Services
Trailing P/E Ratio36.1546391752577
Forward P/E Ratio24.87
Sales & Book Value
Annual Sales$625.16 million
Price / Sales5.18
Cash Flow$2.20 per share
Price / Cash15.94
Book Value$10.42 per share
Price / Book3.37
Net Income$48.85 million
Return on Equity13.61%
Return on Assets6.62%
Cotiviti (NYSE:COTV) Frequently Asked Questions
What is Cotiviti's stock symbol?
Cotiviti trades on the New York Stock Exchange (NYSE) under the ticker symbol "COTV."
How were Cotiviti's earnings last quarter?
Cotiviti Holdings Inc (NYSE:COTV) released its earnings results on Tuesday, October, 31st. The business services provider reported $0.39 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.38 by $0.01. The business services provider earned $174.20 million during the quarter, compared to analysts' expectations of $174.01 million. Cotiviti had a net margin of 13.86% and a return on equity of 13.61%. The business's quarterly revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.36 EPS. View Cotiviti's Earnings History.
When will Cotiviti make its next earnings announcement?
Where is Cotiviti's stock going? Where will Cotiviti's stock price be in 2018?
10 brokers have issued 1-year price objectives for Cotiviti's stock. Their predictions range from $34.00 to $48.00. On average, they expect Cotiviti's share price to reach $40.38 in the next twelve months. View Analyst Ratings for Cotiviti.
Are investors shorting Cotiviti?
Cotiviti saw a increase in short interest in the month of December. As of December 15th, there was short interest totalling 1,054,235 shares, an increase of 104.5% from the November 30th total of 515,544 shares. Based on an average daily volume of 413,988 shares, the short-interest ratio is presently 2.5 days. Approximately 2.8% of the company's stock are sold short.
Who are some of Cotiviti's key competitors?
Some companies that are related to Cotiviti include athenahealth (ATHN), Healthequity (HQY), Allscripts Healthcare Solutions (MDRX), Press Ganey (PGND), Omnicell (OMCL), Evolent Health (EVH), Tabula Rasa HealthCare (TRHC), Castlight Health (CSLT), Craneware (CRW), Emis Group (EMIS), NantHealth (NH), Simulations Plus (SLP), Fluidigm (FLDM), Complete Genomics (GNOM), Medical Transcription Billing (MTBC), Constellation Healthcare Tech (CHT) and Greenway Health (GWAY).
Who are Cotiviti's key executives?
Cotiviti's management team includes the folowing people:
- David L. Swift, Independent Chairman of the Board (Age 58)
- J. Douglas Williams, Chief Executive Officer, Director (Age 55)
- Bradley A. Ferguson, Chief Financial Officer, Senior Vice President (Age 47)
- Adrienne Calderone, Interim Chief Financial Officer (Age 50)
- David Beaulieu, Chief Operating Officer, Senior Vice President (Age 60)
- Damien Creavin, Senior Vice President, Chief Information Officer (Age 61)
- Jonathan Olefson, Senior Vice President, General Counsel, Secretary (Age 41)
- Elizabeth Connolly Alexander, Director (Age 55)
- John L. Maldonado, Director (Age 41)
- Mala Anand, Independent Director (Age 49)
When did Cotiviti IPO?
(COTV) raised $225 million in an initial public offering (IPO) on Thursday, May 26th 2016. The company issued 12,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs and J.P. Morgan acted as the underwriters for the IPO and Barclays, Citigroup, Credit Suisse, Morgan Stanley, RBC Capital Markets, SunTrust Robinson Humphrey, Baird and William Blair were co-managers.
Who owns Cotiviti stock?
Cotiviti's stock is owned by a variety of of retail and institutional investors. Top institutional investors include GW&K Investment Management LLC (0.87%), Schwab Charles Investment Management Inc. (0.19%) and Aurora Investment Counsel (0.04%). Company insiders that own Cotiviti stock include David Beaulieu, Douglas Present, Elizabeth Connolly Alexander, International Corp/Ma Advent, J Douglas Williams, James E Parisi, Jonathan Olefson and Lawrence Connolly. View Institutional Ownership Trends for Cotiviti.
Who sold Cotiviti stock? Who is selling Cotiviti stock?
Cotiviti's stock was sold by a variety of institutional investors in the last quarter, including GW&K Investment Management LLC and Schwab Charles Investment Management Inc.. Company insiders that have sold Cotiviti company stock in the last year include David Beaulieu, Douglas Present, Elizabeth Connolly Alexander, International Corp/Ma Advent, J Douglas Williams, Jonathan Olefson and Lawrence Connolly. View Insider Buying and Selling for Cotiviti.
Who bought Cotiviti stock? Who is buying Cotiviti stock?
How do I buy Cotiviti stock?
Shares of Cotiviti can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cotiviti's stock price today?
One share of Cotiviti stock can currently be purchased for approximately $35.07.
How big of a company is Cotiviti?
Cotiviti has a market capitalization of $3.18 billion and generates $625.16 million in revenue each year. The business services provider earns $48.85 million in net income (profit) each year or $0.97 on an earnings per share basis. Cotiviti employs 3,000 workers across the globe.
How can I contact Cotiviti?
Cotiviti's mailing address is 115 Perimeter Center Place Suite 700, ATLANTA GA, 30346. The business services provider can be reached via phone at 770-379-2800 or via email at [email protected]
MarketBeat Community Rating for Cotiviti (COTV)MarketBeat's community ratings are surveys of what our community members think about Cotiviti and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Cotiviti (NYSE:COTV) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.70||2.60||2.63||2.67|
|Ratings Breakdown: ||0 Sell Rating(s)|
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$40.38||$40.38||$41.20||$38.29|
|Price Target Upside: ||24.04% upside||27.37% upside||18.56% upside||3.47% upside|
Cotiviti (NYSE:COTV) Consensus Price Target History
Cotiviti (NYSE:COTV) Analyst Ratings History
(Data available from 1/20/2016 forward)
Cotiviti (NYSE:COTV) Earnings History and Estimates Chart
Cotiviti (NYSE COTV) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/31/2017||Q3 2017||$0.38||$0.39||$174.01 million||$174.20 million||View||N/A|
|8/1/2017||Q2 2017||$0.34||$0.36||$167.47 million||$167.60 million||View||Listen|
|2/22/2017||Q416||$0.34||$0.39||$161.40 million||$167.90 million||View||N/A|
|11/9/2016||Q316||$0.31||$0.24||$151.40 million||$156.20 million||View||Listen|
|8/9/2016||Q216||$0.30||$0.37||$146.68 million||$158.30 million||View||N/A|
Cotiviti (NYSE:COTV) Earnings Estimates
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Cotiviti (NYSE:COTV)
No dividend announcements for this company have been tracked by MarketBeat.com
Cotiviti (NYSE COTV) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 15.80%
Institutional Ownership Percentage: 86.22%
Cotiviti (NYSE COTV) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|1/12/2018||J Douglas Williams||CEO||Sell||30,000||$33.97||$1,019,100.00||2,766,660|| |
|12/21/2017||J Douglas Williams||CEO||Sell||30,000||$33.22||$996,600.00||2,766,660|| |
|12/13/2017||J Douglas Williams||CEO||Sell||31,547||$31.98||$1,008,873.06||2,768,207|| |
|12/5/2017||Jonathan Olefson||SVP||Sell||15,000||$32.37||$485,550.00||15,149|| |
|11/28/2017||J Douglas Williams||CEO||Sell||8,364||$31.71||$265,222.44||2,759,951|| |
|11/16/2017||J Douglas Williams||CEO||Sell||16,655||$31.25||$520,468.75||2,776,606|| |
|10/31/2017||J Douglas Williams||CEO||Sell||16,655||$34.96||$582,258.80||2,793,261|| |
|10/17/2017||J Douglas Williams||CEO||Sell||16,655||$34.90||$581,259.50||2,809,916|| |
|10/16/2017||David Beaulieu||COO||Sell||5,000||$35.00||$175,000.00||43,133|| |
|10/16/2017||J Douglas Williams||CEO||Sell||8,364||$34.85||$291,485.40||2,809,916|| |
|9/26/2017||J Douglas Williams||CEO||Sell||16,728||$34.95||$584,643.60||2,830,844|| |
|9/25/2017||J Douglas Williams||CEO||Sell||8,364||$34.84||$291,401.76||2,830,844|| |
|9/13/2017||J Douglas Williams||CEO||Sell||16,655||$35.71||$594,750.05||2,843,299|| |
|8/30/2017||J Douglas Williams||CEO||Sell||16,655||$35.04||$583,591.20||2,859,954|| |
|8/17/2017||J Douglas Williams||CEO||Sell||16,655||$35.78||$595,915.90||2,876,609|| |
|8/16/2017||J Douglas Williams||CEO||Sell||8,364||$35.93||$300,518.52||2,876,609|| |
|8/10/2017||Elizabeth Connolly Alexander||Director||Sell||742,349||$37.00||$27,466,913.00||1,614,413|| |
|8/10/2017||International Corp/Ma Advent||Major Shareholder||Sell||9,257,651||$36.87||$341,329,592.37|| |
|7/26/2017||J Douglas Williams||CEO||Sell||16,728||$42.33||$708,096.24||2,893,337|| |
|7/14/2017||Jonathan Olefson||SVP||Sell||5,000||$43.00||$215,000.00||5,149|| |
|7/12/2017||J Douglas Williams||CEO||Sell||16,655||$40.76||$678,857.80||2,909,992|| |
|6/28/2017||J Douglas Williams||CEO||Sell||16,655||$38.19||$636,054.45||2,930,747|| |
|6/16/2017||J Douglas Williams||CEO||Sell||16,655||$37.73||$628,393.15||2,943,302|| |
|5/15/2017||Douglas Present||Director||Sell||14,252||$38.36||$546,706.72||2,357|| |
|4/17/2017||Douglas Present||Director||Sell||15,000||$41.29||$619,350.00||15,000|| |
|3/13/2017||International Corp/Ma Advent||Major Shareholder||Sell||8,011,580||$34.38||$275,438,120.40|| |
|3/13/2017||Lawrence Connolly||Director||Sell||966,174||$36.00||$34,782,264.00|| |
|2/24/2017||Jonathan Olefson||SVP||Sell||5,000||$41.00||$205,000.00||5,000|| |
|2/23/2017||Jonathan Olefson||SVP||Sell||5,000||$39.00||$195,000.00||5,000|| |
|2/9/2017||Jonathan Olefson||SVP||Sell||5,000||$36.00||$180,000.00||5,000|| |
|1/17/2017||Douglas Present||Director||Sell||50,000||$34.16||$1,708,000.00||18,544|| |
|12/9/2016||Jonathan Olefson||SVP||Sell||9,527||$34.85||$332,015.95|| |
|5/26/2016||James E Parisi||Director||Buy||5,000||$18.34||$91,700.00||5,000|| |
Cotiviti (NYSE COTV) News Headlines
|Cotiviti Holdings Inc (COTV) Given Consensus Rating of "Hold" by Brokerages|
www.americanbankingnews.com - January 20 at 4:02 AM
|Reviewing Evolent Health (EVH) and Cotiviti (COTV)|
www.americanbankingnews.com - January 16 at 11:24 PM
|J Douglas Williams Sells 30,000 Shares of Cotiviti Holdings Inc (COTV) Stock|
www.americanbankingnews.com - January 16 at 6:38 PM
|Zacks: Brokerages Anticipate Cotiviti Holdings Inc (COTV) Will Post Earnings of $0.43 Per Share|
www.americanbankingnews.com - January 11 at 7:32 PM
|Cotiviti (COTV) versus Evolent Health (EVH) Head-To-Head Contrast|
www.americanbankingnews.com - January 5 at 11:06 PM
|Research Report Identifies Carpenter Technology, Workhorse Group, BlackRock, Columbia Sportswear, Cotiviti, and Global Brass and Copper with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement|
finance.yahoo.com - January 3 at 8:31 AM
|Cotiviti Holdings Inc (COTV) Short Interest Up 104.5% in December|
www.americanbankingnews.com - January 3 at 4:06 AM
|Cotiviti (COTV) Downgraded by Zacks Investment Research|
www.americanbankingnews.com - January 3 at 12:06 AM
|Cotiviti Holdings, Inc. breached its 50 day moving average in a Bearish Manner : COTV-US : December 29, 2017|
finance.yahoo.com - December 29 at 9:58 AM
|$179.30 Million in Sales Expected for Cotiviti Holdings Inc (COTV) This Quarter|
www.americanbankingnews.com - December 28 at 9:36 PM
|Cotiviti Holdings Inc (COTV) Receives Consensus Recommendation of "Hold" from Analysts|
www.americanbankingnews.com - December 26 at 4:34 AM
|Cotiviti Holdings Inc (COTV) CEO Sells $996,600.00 in Stock|
www.americanbankingnews.com - December 22 at 8:39 PM
|Contrasting Tabula Rasa HealthCare (TRHC) and Cotiviti (COTV)|
www.americanbankingnews.com - December 22 at 1:20 AM
|Cotiviti Holdings, Inc. – Value Analysis (NYSE:COTV) : December 20, 2017|
finance.yahoo.com - December 20 at 5:26 PM
|ETFs with exposure to Cotiviti Holdings, Inc. : December 18, 2017|
finance.yahoo.com - December 18 at 5:28 PM
|Cotiviti Holdings, Inc. breached its 50 day moving average in a Bullish Manner : COTV-US : December 18, 2017|
finance.yahoo.com - December 18 at 9:31 AM
|Contrasting Cotiviti (COTV) & Healthequity (HQY)|
www.americanbankingnews.com - December 17 at 9:30 PM
|Leerink Swann Equities Analysts Reduce Earnings Estimates for Cotiviti Holdings Inc (COTV)|
www.americanbankingnews.com - December 15 at 5:32 PM
|Cotiviti Holdings Inc (COTV) CEO J Douglas Williams Sells 31,547 Shares|
www.americanbankingnews.com - December 14 at 5:34 PM
|Head-To-Head Review: Complete Genomics (GNOM) versus Cotiviti (COTV)|
www.americanbankingnews.com - December 14 at 1:18 AM
|Contrasting Cotiviti (COTV) and Its Rivals|
www.americanbankingnews.com - December 12 at 7:34 PM
|Cotiviti (COTV) vs. Its Competitors Head to Head Analysis|
www.americanbankingnews.com - December 12 at 3:30 PM
|$179.26 Million in Sales Expected for Cotiviti Holdings Inc (COTV) This Quarter|
www.americanbankingnews.com - December 10 at 8:58 AM
|Critical Survey: Cotiviti (COTV) and Its Competitors|
www.americanbankingnews.com - December 10 at 5:22 AM
|Financial Survey: Omnicell (OMCL) and Cotiviti (COTV)|
www.americanbankingnews.com - December 9 at 9:40 AM
|Cotiviti (COTV) Now Covered by Analysts at Deutsche Bank|
www.americanbankingnews.com - December 8 at 11:12 PM
| Analysts Expect Cotiviti Holdings Inc (COTV) to Post $0.43 Earnings Per Share|
www.americanbankingnews.com - December 8 at 11:54 AM
|Cotiviti (COTV) & Its Rivals Critical Comparison|
www.americanbankingnews.com - December 7 at 7:30 PM
|Contrasting Cotiviti (COTV) & Its Rivals|
www.americanbankingnews.com - December 7 at 5:28 PM
|Anemic Earnings Visibility Downgrade Cotiviti Holdings (COTV) to Sell|
investorplace.com - December 7 at 1:42 PM
|Cotiviti Holdings Inc (COTV) SVP Sells $485,550.00 in Stock|
www.americanbankingnews.com - December 6 at 5:46 PM
|Cotiviti (COTV) versus The Competition Head to Head Review|
www.americanbankingnews.com - December 6 at 1:28 AM
|Cotiviti (COTV) vs. Its Rivals Head to Head Comparison|
www.americanbankingnews.com - December 5 at 5:26 PM
|Analyzing Cotiviti (COTV) & Its Rivals|
www.americanbankingnews.com - December 4 at 9:10 AM
|Head to Head Review: Cotiviti (COTV) vs. Its Rivals|
www.americanbankingnews.com - December 4 at 1:34 AM
|Analyzing Cotiviti (COTV) & Allscripts Healthcare Solutions (MDRX)|
www.americanbankingnews.com - December 2 at 5:54 PM
|Analyzing Cotiviti (COTV) & Castlight Health (CSLT)|
www.americanbankingnews.com - December 1 at 11:36 PM
|Cotiviti Holdings, Inc. (COTV) Given Consensus Recommendation of "Hold" by Brokerages|
www.americanbankingnews.com - December 1 at 6:15 AM
|Cotiviti Holdings, Inc. (COTV) CEO J Douglas Williams Sells 8,364 Shares|
www.americanbankingnews.com - November 30 at 4:42 PM
|Q3 2018 Earnings Estimate for Cotiviti Holdings, Inc. (COTV) Issued By First Analysis|
www.americanbankingnews.com - November 29 at 4:28 PM
|Head-To-Head Contrast: Veeva Systems (VEEV) vs. Cotiviti (COTV)|
www.americanbankingnews.com - November 28 at 5:20 PM
|ETFs with exposure to Cotiviti Holdings, Inc. : November 27, 2017|
finance.yahoo.com - November 27 at 6:12 PM
|Critical Contrast: Castlight Health (CSLT) & Cotiviti (COTV)|
www.americanbankingnews.com - November 26 at 7:12 AM
|Head-To-Head Comparison: Cotiviti (COTV) vs. Press Ganey (PGND)|
www.americanbankingnews.com - November 26 at 1:16 AM
|Cotiviti Holdings (COTV) Earnings Momentum Limit Rating|
investorplace.com - November 23 at 1:23 PM
|Cotiviti Holdings (COTV) versus The Competition Head to Head Survey|
www.americanbankingnews.com - November 22 at 11:10 PM
|$179.26 Million in Sales Expected for Cotiviti Holdings, Inc. (COTV) This Quarter|
www.americanbankingnews.com - November 22 at 4:02 AM
|Cotiviti Holdings (COTV) and Its Peers Financial Analysis|
www.americanbankingnews.com - November 20 at 9:16 AM
|Cotiviti Holdings, Inc. (COTV) CEO Sells $520,468.75 in Stock|
www.americanbankingnews.com - November 20 at 8:13 AM
|Cotiviti Appoints R. Halsey Wise to Board of Directors|
finance.yahoo.com - November 16 at 6:04 PM
Cotiviti (NYSE:COTV) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Cotiviti (NYSE:COTV) Income Statement, Balance Sheet and Cash Flow Statement
Cotiviti (NYSE COTV) Stock Chart for Saturday, January, 20, 2018